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ABSTRACT
This study was designed to test the lipid-lowering and antioxidative activities of three phenolic compounds, caffeic acid, ferulic
acid and coumaric acid. Four groups of rats were given a semisynthetic diet containing 3% of cholesterol for 6 weeks. The control
group only received a high cholesterol diet, whereas the other three groups received a diet including 0.2% of caffeic acid, 0.2% of
ferulic acid and 0.2% of coumaric acid. The caffeic acid, ferulic acid and coumaric acid significantly lowered the plasma lipid and
hepatic cholesterol levels compared to those in the control (p < 0.05). The hepatic HMG-CoA reductase activity was significantly
lower in the caffeic acid group than in the ferulic acid and coumaric acid groups ( p < 0.05), while the hepatic ACAT activity was
significantly lower in the caffeic acid, ferulic acid and coumaric acid groups compared to the control group ( p < 0.05). The overall
potential of the antioxidant system was significantly enhanced by the caffeic acid, ferulic acid and coumaric acid supplements as
the plasma and hepatic TBARS levels were lowered while the hepatic SOD activities and GSH concentration were elevated in the
high-cholesterol-fed rats (p < 0.05). Furthermore, these results indicated that the supplementation of caffeic acid, ferulic acid and
coumaric acid boosted the antioxidant activity in rats and promoted the excretion of neutral sterol and acidic sterol (p < 0.05),
thereby leading to a decreased absorption of dietary cholesterol as well as lower plasma, hepatic cholesterol and promoted excretion
of fecal sterols.
Key words: caffeic acid, ferulic acid, coumaric acid, HMG-CoA reductase, ACAT, fecal sterols, antioxidant enzymes

INTRODUCTION
Although flavonoids are non-energetic and not
considered as indispensable vitamins, their supply,
either individually or in a complex mix, may have a positive effect on health. A high consumption of flavonoids
has been previously exert reported to contribute to a
decreased risk of coronary heart diseases due to lowering
the serum cholesterol and triglycerides in rats (1). However, it is still unclear exactly which substances in fruits
and vegetables are responsible for the observed inverse
association with cardiovascular diseases, which could be
attributed to an antioxidant or other constituents, such
as fiber or phytochemicals (2). Most flavononoids exhibit antioxidant activity in both aqueous and lipid-assay
systems and their free radical scavenging activity can
* Author for correspondence. Tel: +886-5-3622-889; Fax: +886-53622-899; E-mail: yhyeh@mail.toko.edu.tw

largely be predicted on the basis of their chemical structure. Flavonoids and phenolics are known to decrease
the risk of tumors, inflammation and bacterial and viral
infections (3,4), and they exhibit inhibitory effects on
membrane lipid peroxidation(5).
Plasma cholesterol concentration can be regulated
by the biosynthesis of cholesterol, removal of cholesterol
from the circulation, absorption of dietary cholesterol
and excretion of cholesterol via bile and feces. Cellular
cholesterol homeostasis is very important for the prevention of cardiovascular diseases and numerous studies have
already reported on the beneficial effects of 3-hydroxy3-methylglutaryl-CoA (HMG-CoA) reductase and acylCoA; cholesterol acyltransferase (ACAT) inhibitors on
hypercholesteolemia and atherosclerosis(6,7). Previous
reports also demonstrate that the flavonoids hesperidin and
naringin plus their aglycones lower the plasma and hepatic
cholesterol as well as HMG-CoA reductase activity(8,9).
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In association with cardiovascular diseases, there are
relatively few reports on the physiological functions of
caffeic acid, ferulic acid and coumaric acid. Polyphenol
glycoside can relax smooth muscles and it was observed
to lower hepatic and blood cholesterol levels (10). Meanwhile, caffeic acid, ferulic acid and coumaric acid and
other polyphenol compounds seemed to have direct antioxidant effects by scavenging free radicals as phenolic
bioflavonoids (11). However, the overall effects of bioflavonoids and phenolic compounds on the cholesterol metabolism and antioxidative status still require clarification.
Accordingly, the present study was aimed to investigate
caffeic acid, ferulic acid and coumaric acid supplements
alter the cholesterol metabolism and activities of antioxidant enzymes.

an air-conditioned room (23 ± 1°C, 50-60% humidity)
light for 12 hr/day (7 AM to 7 PM). Experimental protocol was approved by the Institutional Animal care and
Use, Committee of Toko University. After acclimatizing
for 2 week with a commercial non-purified diet (Rodent
Laboratory Chow 5001, Purina Co., USA), 24 rats were
divided six rats in each group into four groups. The
composition of the basal and all treatment diets is listed
in Table 1. In previous studies hypercholesterol diet
induce increase cholesterol, triglyceride (TG) and oxidative stress (12-14). The diets were synthesized as described
previously by the American Institute of Nutrition(15) and
included: basal diet (control diet), caffeic acid diet (0.2%
caffeic acid in diet), ferulic acid diet (0.2% ferulic acid)
and coumaric acid diet (0.2% coumaric acid).
Rats were fasted for 10 hr before the experiment,
blood was obtained by tail vein puncture and the rats
were weighed and euthanized (with diethyl ether) on the
6th week. The plasma of blood samples were collected by centrifugation (1000 × g for 15 min) of the whole
blood and examined for aspartate transaminase (AST),
alanine transaminase (ALT) and alkaline phosphatase
(ALP) activites. The cholesterol, HDL-cholesterol and
TG, levels in the plasma and hepatic lipids were determined by enzymatic assay using commercially enzymatic kit with Selectra Analyser (Merck Co. Ltd, Germany).
Livers and kidneys of the rats were quickly excised and
weighed. Both relative ratios of liver and kidney weight

MATERIALS AND METHODS
I. Reagents
Caffeic acid, ferulic acid and coumaric acid standards were purchase from Sigma (St. Louis, MO, USA).
II. Animals
Male weanling Wistar rats were purchased from the
National Laboratory Animal Center. They were kept in

Table 1. Composition of the experimental diets for animal diet of caffeic acid, ferulic acid and coumaric acid
Ingredient

Diets
Base diet (%)

Caffeic acid diet (%)

Ferulic acid diet (%)

Coumaric acid diet (%)

Casein

20

20

20

20

Methionine

0.3

0.3

0.3

0.3

Cellulose

5

5

5

5

Corn oil

2

2

2

2

Cholesterol

3

3

3

3

Caffeic acid

0

0.2

0

0

Ferulic acid

0

0

0.2

0

Coumaric acid

0

0

0

0.2

Choline

0.2

0.2

0.2

0.2

Mineral mix(a)

3.5

3.5

3.5

3.5

Vitamin mix(b)

1

1

1

1

Corn starch

30

29.8

29.8

29.8

Sucrose

35

35

35

35

(a) Minerals per 100 g diet: NaCl 7.4 g, K 2C6H5O7 H2O 22 g, K 2SO4 5.2 g, CaHPO4 50 g, MgO 2.4 g, FeC6H5O7 5H2O 0.6 g, MnCO3 0.35 g,
CuCO3 30 mg, CrK(SO4)2 12H2O 55mg, CoCl2 6H2O 10 mg, KI 1 mg, ZnCO3 160 mg.
(b) Vitamin per 100 g diet: thiamine 100 mg, riboflavin 150 mg, pyridoxine HCl 100 mg, nicotinamide 1000 mg, D-panthenate 500 mg, folic
acid 50 mg, vitamine B12 0.1 mg, vitamin A 2.5× 105 IU, vitamin E 100 mg, calciferol 2 × 104 IU, vitamin C 3.7 × 103 mg.
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to body weight were obtained. The liver was stored at
-40°C for glutathione (GSH) and thiobarbituric acidreactive substances (TBARS) determinations.

lithocholic acid and glycocholic acid in each sample.

III. HMG-CoA Reductase

Appropriate liver tissues were dissected, weighed,
immersed in liquid N2 generally within 60 s of death, and
kept frozen at -70°C. Prior to enzyme determinations,
thawed tissue samples were homogenized in 20 volumes
of ice cold 50 mM phosphate buffer (pH 7.4), centrifuged
at 3200 × 3 g for 20 min at 5°C. The supernatant fraction
was used for the determination of antioxidant enzymes.

Microsomal HMG-CoA reductase activity was
measured using [14C] HMG-CoA and an NADPH regenerating system as previously described(16). Each reaction
mixture contained 0.1 mg of protein, as determined by a
biuret protein assay, and was incubated for 10 min. The
product [14C] mevalonate was converted to the lactone and
isolated by thin layer chromatography(16). Enzyme activity was expressed as nmol/min/mg of microsomal protein.
IV. ACAT Activities
The intestine was opened longitudinal, mucosal cells
were scraped off using a microscope slide and suspended in
0.154 M potassium phosphate (pH 7.4) containing 0.25 M
sucrose. The liver or intestinal mucosal cell suspension was
homogenized in 0.25 M sucrose solution and centrifuged
to obtain a microsome fraction(17,18). The activity of ACAT
was determined by the formation of cholesteryl [14C] oleate
from [14C] oleoyl-CoA and endogenous cholesterol as
previously described(18). The radioactivity was expressed
as PSL (photo stimulated luminescense). Cholesterol in
liver microsome was extracted with chloroform methanol
(2:1 v/v) and measured enzymatically.
V. Fecal Sterols
Analysis of fecal neutral sterols were carried out in
a Hewlett Packard Gas Chromatographer (GC) Model
873 equipped with a hydrogen flame ionization detector
and a dual pen recorder. A 6 ft long (3 mm i.d.) u-shaped
column was silanized and packed with 3% SE-30 on 100120 mesh Supelcoport. Helium was used as a carrier gas
at a flow rate of 40-50 mL/min and an inlet pressure of
40 psi. Operating temperatures for the column, inlet and
detector were 260, 280 and 280°C, respectively. Daily
neutral sterol excretion was calculated based on the
amount of cholesterol, coprostanol and coprostanone in
each sample. The fecal acid sterols were determined by
using a Hitachi Liquid Chromatographer (Hitachi, Ltd,
Tokyo) consisting of a Model L-6200 pump, a Rheodyne
Model 7125 syringe loading sample injector, a Model L4000 UV-Vis detector set at 210 nm and a Model D-2500
Chromato-integrator. A Lichrospher 100 RP-18 reversephase column (5 μm, 25 × 0.3 cm 2 i.d., E. Merck) was
used for separation. The mixed solvent of 0.3% ammonium carbonate solution-acetonitrile was used as the mobile
phase. The system of mobile phase was as follows: the
ratio of both solution from 73:27 for 10 min, 68:32 for 10
min and then to 50:50 for 10 min. The flow rate was 0.8
mL/min(19). The daily acid sterol excretion was calculated based on the amount of cholic acid, deoxycholic acid,

VI. Antioxidant Activities

(I) Catalase Activity
Catalase activity of 1% Triton X-100-treated supernatant was determined at 20°C by the disappearance of
H 2O2 at 240 nm(20,21). One unit of catalase represents the
decrease of 1 μmol of H 2O2 per minute. The Se-dependent isoenzyme of glutathione peroxidase (Se-GPx) was
assayed at 25°C(21,22), where NADPH oxidation was
followed by the absorbance at 340 nm in the presence of
reduced glutathione (GSH) and H 2O2(22). To correct for
spontaneous reactions in the absence of enzyme, blanks
were run without sample and then subtracted from the
assay values(21). One unit of GPx is defined as the amount
of enzyme that oxidizes 1 μmol of NADPH per minute.
Total superoxide dismutase (Total-SOD) activity was
assayed by the inhibition, at 25°C, of pyrogallol autoxidation by SOD (with and without sample) and was followed
kinetically at 420 nm(23). One unit of SOD is defined as
the amount of enzyme that causes 50% inhibition of pyrogallol autoxidation. Changes in absorbance were read
on a SPECTRAmax Plus microplate spectrophotometer
(Molecular Devices Corp. Sunnyvale, CA, USA) and
analyzed using SOFTmax Pro software (Molecular Devices Corp.). All enzyme activities are expressed per mg
protein. Protein content for separate tissue samples was
determined by the method of Lowry et al.(24).
(II) SOD Activity Assays
SOD activity was assayed using a SOD assay kit
based on the cytochrome c-xanthine oxidase method(25,26).
One unit of activity was defined as the amount of enzyme
which inhibits the rate of cytochrome c reduction by 50%.
Different concentrations of MnCl 2 were added to the
assay system in order to address the effects of MnCl 2 on
the activities.
(III) Levels of GSH Measurement
GSH reacts non-enzymatically with DTNB to yield
GSSG and TNB. GSSG is then reduced enzymatically by
NADPH and GR to regenerate GSH. Concentrations of
DTNB, NADPH and GR are chosen such that the rate of
the overall reaction is linearly proportional to the concentration of total GSH. The rate of formation of TNB is
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followed spectrophotometrically, and assay is calibrated
using standards. If the sample is reacted with 2-vinylpyridine and GSH is derivatized, and only GSSG is detected
during subsequent assay(27).

by using the HPLC system at an excitation 515 nm and
an emission 550 nm on a Hitachi Fluorescence Detector
(Japan)(28).
VII. Atherogenic Index

(IV) TBARS Concentration

The atherogenic index (AI) was calculated using the
following formula: AI = (total cholesterol-HDL-cholesterol)/HDL-cholesterol.

Lipid peroxidation activities in the liver and plasma
were assayed by measurement of MDA, an end-product
of peroxidized fatty acids, and TBA reaction product.
The sample of 20% liver homogenate was mixed with
1.0 mL 0.4% TBA in 0.2 N HCl and 0.15 mL 0.2% BHT
in 95% ethanol. The samples were incubated in a 90°C
water-bath for 45 min. After incubation, the TBA-MDA
adduct was extracted with isobutanol. The isobutanol
extract was mixed with methanol (2:1) prior to injection
into the HPLC system. The supernatant was examined

VIII. Statistical Analysis
Statistical analysis for differences among experimental groups was performed by the one-way analysis of variance procedure and Duncan’s new multiple range tests(29).
A p value < 0.05 was considered statistically significant.

Table 2. Effect of caffeic acid, ferulic acid and coumaric acid supplementation on the body weight, liver and kidney weight to body weight in
high cholesterol-fed rats.
Control*

Caffeic acid

Ferulic acid

Coumaric acid

385 ± 23

386 ± 26

392 ± 25

393 ± 28

Liver
weight/body weight (%)

2.23 ± 0.15

2.26 ± 0.16

2.23 ± 0.15

2.27 ± 0.16

Kidney
weight/body weight (%)

2.56 ± 0.15

2.58 ± 0.13

2.6 ± 0.16

2.63 ± 0.18

Groups
Body weight (g)

*Data represent mean ± SD.
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Figure 1. Effect of caffeic acid, ferulic acid and coumaric acid supplementation on plasma lipids in high cholesterol-fed rats. A-E: values in the
same week with different superscript are significantly different (p < 0.05). (A): Plasma (total cholesterol); (B): Plasma (HDL-cholesterol); (C):
Plasma (TG); (D): Plasma (HDL-C/total-C); (E): Plasma (atherogenic index, AI).
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RESULTS
I. Body Weight, Liver and Kidney Weight to Body Weight
There was no significant difference in the body
weight, liver and kidney weight to body weight among
various groups (Table 2). Accordingly, these areas were
not seemingly affected by the three flavonoid supplements.
II. Plasma and Hepatic Lipids
The supplementation of caffeic acid, ferulic acid and
coumaric acid significantly lowered both plasma cholesterol and triglyceride concentrations compared to the
control group (Figure 1). The HDL-cholesterol concentration did not differ between the groups, however, the
supplementation of caffeic acid significantly increased
the HDL-C/total-C ratios compared to the other groups.
The AI was significantly lower in the caffeic acid, ferulic
acid and coumaric acid groups than in the control group.
In addition, the AI and total cholesterol level in plasma
were both significantly lower in the caffeic acid, ferulic
acid and coumaric acid group than in the control group.
In contrast to the plasma lipids, hepatic triglyceride

0.9

mmol/g

(B)

1.2

III. Hepatic HMG-CoA Reductase and ACAT Activities
The hepatic HMG-CoA reductase activity was significantly lowered by the caffeic acid supplement compared
to other groups (Figure 3). However, the hepatic ACAT
activity was lower in the caffeic acid, ferulic acid and
coumaric acid groups than in the control group.
IV. Fecal Sterols
The daily excretion of fecal sterols is shown in Figure
4. The effect of the caffeic acid, ferulic acid and coumaric
acid supplementation did result in certain changes in the
fecal sterol under the cholesterol-fed conditions. As such,
when compared with the control group, the caffeic acid
supplement induced a significant increase in the excretion
of neutral, and total fecal sterols, while the coumaric acid
supplement induced an increase in the excretion of acidic
and total fecal sterols.

0.5

Control
Caffeic acid
Ferulic acid
Coumaric acid

0.4

b

0.6
a

a

a

mmol/g

(A)

level was not different among groups (Figure 2), yet the
supplementation of caffeic acid, ferulic acid and coumaric acid did significantly lower the hepatic cholesterol
content compared to the control group.

0.3

0.3

a

a

a

a

0.2
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Figure 2. Effect of caffeic acid, ferulic acid and coumaric acid supplementation on hepatic lipids in high cholesterol-fed rats. A-B: values in the
same week with different superscript are significantly different (p < 0.05). (A): Liver (cholesterol); (B): Liver (TG).
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Figure 3. Effect of caffeic acid, ferulic acid and coumaric acid supplementation on hepatic ACAT activity and HMG-CoA reductase activity
in highcholesterol fed rats. A-B: values in the same week with different superscript are significantly different ( p < 0.05). (A): HMG-CoA
reductase; (B): ACAT activity.
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Figure 4. Effect of caffeic acid, ferulic acid and coumaric acid supplementation on fecal sterol concentration content in high cholesterol-fed
rats. A-C: values in the same week with different superscript are significantly different ( p < 0.05). (A): Total fecal sterol; (B): Neutral sterol;
(C): Acidic sterol.
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Figure 5. Effect of caffeic acid, ferulic acid and coumaric acid supplementation on SOD, CAT and GSH activities in high cholesterol-fed rats.
A-C: values in the same week with different superscript are significantly different (p < 0.05). (A): SOD; (B): CAT; (C): GSH.
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Figure 6. Effect of caffeic acid, ferulic acid and coumaric acid supplementation on plasma and hepatic TBARS concentrations in high cholesterolfed rats. A-B: values in the same week with different superscript are significantly different (p < 0.05). (A): Liver (TBARS); (B): Plasma (TBARS).

V. Hepatic Antioxidant Enzyme Activities and Plasma and
Hepatic TBARS Levels
No marked differences in the CAT activities were
observed among groups (Figure 5). However, the activities of SOD and GSH were significantly higher in the
caffeic acid, ferulic acid and coumaric acid groups than
in the control group.
The levels of plasma and hepatic TBARS were
significantly lower in the caffeic acid, ferulic acid and

coumaric acid groups than in the control group (Figure
6). Among all three compounds, the caffeic acid and
ferulic acid supplement was more effective in lowering
the hepatic TBARS level.

DISCUSSION
Flavonoids are now widely accepted as physiologic
antioxidants that have a significant potential to protect
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against many degenerative diseases linked to free radical-related tissue damage. The health benefits of polyphenols would appear to arise from their antioxidant
activity and capacity to protect critical macromolecules,
such as chromosomal DNA, structural proteins and
enzymes, LDL and membrane lipids, from damage from
exposure to reactive oxygen species (ROS)(30,31). Interest in polyphenols as antioxidants has been centered on
a group referred to as flavonoids, which share a common
molecular structure of diphenylpropane.
The present study investigated the effects of dietary
caffeic acid, ferulic acid and coumaric acid in order to
determine their possible roles in a high-cholesterol fed
state. The results suggest that the plasma lipid-lowering and antioxidative effects of caffeic acid, ferulic acid
and coumaric acid supplements were very potent in high
cholesterol-fed rats.
Liver is the major site for the synthesis and net excretion of cholesterol, and hepatic HMG-CoA reductase
activity can normally be suppressed under high-cholesterol feeding conditions by negative feedback control(32).
In the current study, the plasma cholesterol concentration
was lowered by caffeic acid, ferulic acid and coumaric
acid supplements, although caffeic acid exhibited a more
potent biological effect on lowering the plasma cholesterol and hepatic HMG-CoA reductase activity than
ferulic acid and coumaric acid. These results can also
be supported by other previous findings. For instance,
Santos et al. (33) reported on the hypolipidemic effect of
phenolic acid by the intraperitoneal route with a dose
of 5 mg/body weight. Furthermore, the intraperitoneal
injection of caffeic acid at 30 mg/week for a period of 10
weeks was previously found to lower the plasma triglyceride, total-C, and LDL-C levels in spontaneously hypertensive rats, while increasing the plasma HDL-C level in
normal Wistar rats (34). Hypocholesterolemic effects have
been observed in both genetically hypercholesterolemic
(RICO) and normocholesterolemic (RAIF) rats when
fed a high fat diet (35). In the current study, the plasma
triglyceride concentration was lower in the three flavonoid supplemented groups, although the hepatic triglyceride content did not differ significantly among groups.
The reduced ACAT activity in these groups may have
led to less cholesteryl ester available for VLDL packing,
thereby resulting in a reduction of VLDL secretion from
the liver, as suggested by Carr et al.(36).
The cholesterol-lowering activity of other flavonoids
was also identified in previous studies (8,9). As such, the
present results are somewhat different from previous
observations, where the supplement of a citrus bioflavonoid lowered both the plasma cholesterol concentration and the fecal neutral sterol in high cholesterol-fed
rats (8,9). Recently, Kurowska et al.(37) reported that citrus
juices induce the reduction of LDL cholesterol as well
as cholesterol excretion in rabbits fed a semi-purified
cholesterol-free diet. Furthermore, same studies suggested that citrus bioflavonoids inhibit hepatic HMG-CoA

reductase during their cholesterol-lowering action(8,9).
According to the results of the current study,
although caffeic acid inhibited the hepatic HMG-CoA
reductase activity, the mode of its cholesterol-lowering
action was not the same as that of other citrus bioflavonoids in high cholesterol-fed rats. Meanwhile, Chan et
al.(38) recently reported that epicatechins produce a hypolipidemic effect in a high fat diet without affecting the
hepatic HMG-CoA reductase and ACAT activities. As
such, it would appear that the decrease in the plasma
cholesterol concentration resulting from the caffeic
acid, ferulic acid and coumaric acid supplements may be
resulted due to the increased fecal sterol, which in turn
led to a decreased absorption of dietary cholesterol. The
action of ferulic acid and coumaric acid in the cholesterol-lowering mechanism appeared to be similar to that
of caffeic acid except for the HMG-CoA reductase activity, which is known to be down-regulated by the body
cholesterol and can be inhibited by HMG-CoA reductase
inhibitors. In this case, ferulic acid and coumaric acid
did not exhibit any effective inhibition of the HMG-CoA
reductase activity.
Dietary caffeic acid, ferulic acid and coumaric acid
did have a significant affect on the two hepatic antioxidant enzyme activities, SOD and GSH, along with the
plasma and hepatic TBARS levels. SOD converts superoxide radicals into hydrogen peroxide, which is then
converted to water by both CAT and GSH. As a result,
these three enzymes can prevent damage by detoxifying
reactive oxygen species. The levels of plasma and hepatic TBARS in the caffeic acid, ferulic acid and coumaric acid treated animals showed a significant reduction,
thereby indicating a decreased rate of lipid peroxidation.
The overall potential of an antioxidant defense was greater in the caffeic acid supplemented rats than in the ferulic
acid and coumaric acid group. A concomitant increase
in the antiperoxidative enzymes, namely SOD and GSH,
was observed in the caffeic acid group, and both enzymes
play an important role in scavenging toxic intermediates of incomplete oxidation in the body. The significant
elevation of SOD activity also suggests that the free-radical scavenging activity of this enzyme is only effective
when it is accompanied by an increase in the activity
of catalase and/or GSH. This is because SOD generates
hydrogen peroxide as a metabolite, which is more toxic
than oxygen radicals in cells and needs to be scavenged
by catalase or GSH(39). As such, a concomitant increase
in catalase and/or GSH activity is essential if a beneficial
effect from the high SOD activity is expected.
Cholesterol diet may induce lipid peroxidation and
reduce diet palatability in rats. TBARS is an end-product
of lipid peroxidation. The level of TBARS in the liver
was increased when the rats were fed with cholesterol.
This means that the oxidative stress caused by feeding with cholesterol was due to the induction of the lipid
peroxidation of liver cells. The level of TBARS in the
liver of rats was significantly reduced when the rats were
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fed with the supplement of caffeic acid, ferulic acid or
coumaric acid. This result is the same as that reported
previously(40-44). Therefore, it is reasonable to assume
that caffeic acid, ferulic acid and coumaric acid may act
as a good scavenger in reducing the production of lipid
peroxidation(45-50). Meanwhile, the function of GSH to
protect biological organisms from xenobiotic injuries is
well known(51,52-54).
Lipid peroxidation is a chemical mechanism capable
of disrupting the structure and function of the biological
membranes that occurs as a result of free radical attacking on lipids. When reactive oxygen species (ROS) begin
to accumulate, hepatic cells exhibit a defensive mechanism by various antioxidant enzymes. The main detoxifying systems for peroxides are catalase and GSH(55).
Catalase is an antioxidant enzyme, which destroys H 2O2
that can form a highly reactive hydroxyl radical in presence of iron as a catalyst (56). By participating in the
glutathione redox cycle, GSH together with GSH-Px
converts H 2O2 and lipid peroxides to non-toxic products.
Reduced activity of one or more antioxidant systems due
to the direct toxic effect of cholesterol leads to increased
lipid peroxidation, oxidative stress, and hepatotoxicity.
In the current study, cholesterol depleted GSH reservoir and reduced catalase and GSH-Px activities. These
results are in harmony with other investigations (57). For
example, cholesterol induced hepatotoxicity was exacerbated by GSH depletion. In the current study, the depletion of GSH reservoir can account for the inhibition of
GSH-Px activity. In addition, high levels of peroxides
may explain catalase activity inhibition(58).
Caffeic acid, ferulic acid and coumaric acid supplementation in our study significantly mitigated cholesterol
induced oxidative stress. In addition, caffeic acid, ferulic acid and coumaric acid inhibited lipid peroxidation,
diminished the decrease in catalase and GSH-Px activities, and abrogated GSH depletion induced by cholesterol.
Caffeic acid, ferulic acid and coumaric acid has
been demonstrated to function as a direct antioxidant
that scavenges or quenches oxygen free radicals, thus
inhibiting lipid peroxidation, and as an indirect antioxidant that prevents the increase in membrane permeability resulted from oxidant injury in many tissues including liver and plasma (59). Caffeic acid, ferulic acid and
coumaric acid might stimulate s-nitrosylation of GSH
producing s-nitrosoglutathione, which is approximately
100 times more potent than the classical GSH. In addition, s-nitrosylation of cysteine residues by nitrosoglutathione can inactivate caspase-3, thus preventing hepatic
cell apoptosis (60). Moreover, caffeic acid, ferulic acid and
coumaric acid might lessen cholesterol induced oxidative
injury and may be capable of lowering or slowing down
oxidative-stress (61,62). In summary, the data presented in
this paper show that administration of caffeic acid, ferulic acid and coumaric acid is a safe and effective way of
lowering cholesterol.
This study idemonstrated a decrease in the plasma

lipid and hepatic cholesterol levels, increase in the fecal
sterols and enhanced antioxidative capacity in rats
supplemented with caffeic acid, ferulic acid and coumaric acid. Accordingly, these results indicate that caffeic
acid, ferulic acid and coumaric acid supplements both
decreased the cholesterol absorption in high cholesterolfed rats. Since the cholesterol intake was about the same
for all groups, the supplementation of these compounds
appeared to promote an increase in the fecal sterol. It is
also worth mentioning that caffeic acid exhibited a greater inhibitory effect on hepatic HMG-CoA reductase than
ferulic acid and coumaric acid. However, more studies
are needed, with various animal models, to explain the
lipid-lowering action of these bioflavonoids.
In conclusion, we suggest that: (a) the imbalance
between production of oxygen free radicals and the
endogenous antioxidant defense system, as a result of the
effect of cholesterol, is the main mechanism responsible
for peroxide accumulation; and (b) caffeic acid, ferulic acid and coumaric acid reduces the oxidative stress
through the inhibition of lipid peroxidation (a widely
known mechanism).
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